Program Release: October 26, 2021
Expiration Date: October 26, 2023
Estimated time to complete: 180 Minutes
There are no prerequisites for participation.

All physicians should be able to identify and know how to treat cutaneous malignancies. Melanoma incidence in particular is increasing in this country and clinicians should be aware of the diagnosis process, pathology, identification on exam, and management of tumors. The goal of the program is to help strengthen knowledge about fundamentals of cutaneous oncology for primary Dermatologists, dermatological surgeons, and oncologists, and primary care doctors to be able to work together as a team to effectively treat patients with skin cancers.

 This virtual educational activity will educate primary care clinicians and other non‐dermatology providers on the fundamentals of cutaneous oncology. The program will commence with a broad discussion on the common types of skin cancer and progress into a more in‐depth discussion on advanced concepts that should be understood by the primary care clinician to effectively co-manage patients that are undergoing advanced therapy. All information will be presented in the case‐based format.

Method of Participation and How to Receive CME Credit

• Review the activity objectives, faculty information, and CME information prior to participating in the activity.
• View the three CME presentations
• Complete the CME activity post-test and evaluation at the conclusion of the activity in order to receive a credit certificates

Faculty Disclosure

The Warren Alpert Medical School is committed to presenting CME activities that promote improvements and/or quality in health care and are developed free of the control of ineligible companies. It is our policy to ensure that our activities are balanced, independent, objective, scientific, and in compliance with ACCME and other regulatory requirements. Anyone who is in a position to control the content of a CME presentation is expected to disclose all financial relationships he/she has had within the past 24 months with ineligible companies. All disclosures have been reviewed and any potential conflicts of interest have been mitigated prior to this presentation by the Brown University CME Office. This activity may include discussion of off-label or investigative drugs uses. Speakers are aware that it is their responsibility to disclose to the audience this information.

Faculty Disclosure/Conflict of Interest

The following speakers and/or planning committee members* have disclosed the following relevant relationships:

Oliver J. Wisco, DO, FAAD, FACMS^*
Paid Education Speaker: Castle Biosciences

The following speakers and planning committee members* have disclosed no relationships:

Maria Constantinou, MD 
Christopher P. Elco, MD, PhD 
Sameer Gupta, MD, Mphil* 
John C. Kawaoka, MD, FAAD 
Thomas J. Miner, MD 
Nicole A. Negbenebor, MD*^ 
Mohamedyakub A. Puthawala, MD
Leslie Robinson-Bostom, MD
Michael P. Vezeridis, MD, FACS

Disclaimer and Privacy Policy

Privacy Policy: The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants and educational collaborators. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. CME collects only the information necessary to provide you with the services that you request.

Disclaimer: This educational program is designed to present scientific information and opinion to Health professionals, to stimulate thought, and further investigation.